Kumar Aalok, Anuranjani Lavanya
Department of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Department of Obstetrics and Gynaecology, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.
Taiwan J Ophthalmol. 2022 May 19;12(3):312-316. doi: 10.4103/tjo.tjo_12_22. eCollection 2022 Jul-Sep.
Our study aims to find the incidence of ocular manifestations and to investigate the relation of ocular manifestations with the disease severity among coronavirus disease 2019 (COVID-19) patients.
Our study is a cross-sectional study done between May 15, 2020, and April 15, 2021, at Hind Institute of Medical Sciences, Lucknow, India. All COVID-19 patients who got admitted to our center between May 15, 2020, and April 15, 2021, were included in our study. We included 261 patients in our study. Diagnosis of COVID-19 was made by testing the nasal and pharyngeal swabs by (reverse transcriptase-polymerase chain reaction [RT-PCR]). An RT-PCR test positive was the criteria for admission in the COVID ward. Statistical analyses were performed using the Mann-Whitney -test, Chi-square test, and Kolmogorov-Smirnov test. < 0.01 was considered statistically significant.
We included 261 patients in our study. Out of 261 patients, ocular manifestations were found in 43 (16.4%) patients. The patients with ocular manifestations had higher neutrophil counts, erythrocyte sedimentation rate (ESR), procalcitonin (PCT), C-reactive protein (CRP), and D-dimer values ( < 0.001). Patients with ocular manifestations were relatively more symptomatic concerning fever and myalgia.
The incidence of ocular manifestations in COVID-19 patients was 16.4%. Ocular manifestation was significantly associated with raised neutrophil counts, CRP, ESR, PCT, and D-dimer values. Ocular manifestation was also significantly associated with higher body temperature and higher mean age. The findings of the study are suggestive of more severe disease in patients of COVID-19 with ocular manifestations.
我们的研究旨在找出2019冠状病毒病(COVID-19)患者眼部表现的发生率,并调查眼部表现与疾病严重程度之间的关系。
我们的研究是一项横断面研究,于2020年5月15日至2021年4月15日在印度勒克瑙的印度医学科学研究所进行。2020年5月15日至2021年4月15日期间入住我们中心的所有COVID-19患者均纳入我们的研究。我们的研究纳入了261名患者。通过(逆转录聚合酶链反应[RT-PCR])检测鼻拭子和咽拭子来诊断COVID-19。RT-PCR检测呈阳性是进入COVID病房的标准。使用曼-惠特尼检验、卡方检验和柯尔莫哥洛夫-斯米尔诺夫检验进行统计分析。P < 0.01被认为具有统计学意义。
我们的研究纳入了261名患者。在261名患者中,43名(16.4%)患者出现了眼部表现。出现眼部表现的患者中性粒细胞计数、红细胞沉降率(ESR)、降钙素原(PCT)、C反应蛋白(CRP)和D-二聚体值更高(P < 0.001)。出现眼部表现的患者在发热和肌痛方面症状相对更明显。
COVID-19患者眼部表现的发生率为16.4%。眼部表现与中性粒细胞计数、CRP、ESR、PCT和D-二聚体值升高显著相关。眼部表现还与更高的体温和更高的平均年龄显著相关。该研究结果表明,有眼部表现的COVID-19患者病情更严重。